The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Ahouansou N, Georges M, Beltramo G, Aswad N, Hassani Y, Bonniaud P

Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?

Infectious diseases now. 2021;51(7):618-621

Foong KS, Lee A, Pekez M, Bin W

Imipenem/cilastatin-induced acute eosinophilic pneumonia.

BMJ case reports. 2016;2016

Adar T, Tayer-Shifman O, Mizrahi M, Tavdi S, Barak O, Shalit M

Dapsone induced eosinophilic pneumonia.

European annals of allergy and clinical immunology. 2012;44(3):144-6

Rether C, Conen A, Grossenbacher M, Albrich WC

A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Infection. 2011;39(6):583-5

Tseng OL, Kelsall JT, Wilcox PG

Piperacillin-associated pulmonary infiltrates with eosinophilia: a case report.

Canadian respiratory journal. 2010;17(2):e24-6

Sitbon O, Bidel N, Dussopt C, Azarian R, Braud ML, Lebargy F, Fourme T, de Blay F, Piard F, Camus P

Minocycline pneumonitis and eosinophilia. A report on eight patients.

Archives of internal medicine. 1994;154(14):1633-40